drugset / Trial / NCT00042601
Evaluation of the Effect of Pramlintide on Satiety and Food Intake
RandomizedCrossoverTriple-blindTreatment
Summary
This is a single center, randomized, blinded, placebo-controlled, two-period, cross-over study to evaluate the effect of pramlintide on satiety and food intake in normal-weight and obese non-diabetic subjects and in insulin-treated subjects with type 1 and type 2 diabetes.
Timeline
- Start
- 2002-07
- Primary completion
- 2003-10
- Completion
- 2003-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pramlintide | Peptide | 0.6 mg/ml | Subcutaneous |